AppointmentsFormer Clinton Advisor Joins FoliuMed Advisory Board

Former Clinton Advisor Joins FoliuMed Advisory Board

-

FOLIUMED, a medical cannabis company with manufacturing and R&D in Germany and cultivation in South America, is pleased to announce the appointment of Howard M. Glicken to its Advisory Board.

Howard M. Glicken served as a private sector advisor to the Clinton Administration on Latin American affairs and was the President´s private sector delegate to the Inaugurations of Presidents of Argentina, Uruguay, Peru and Ecuador. He testified before the US Congress on the Free Trade Area of the Americas and is a member of the U.S./Brazil Business Development Council.

“What impresses me most about FoliuMed is its leadership team led by founder Oliver Zugel,” says Glicken. “Since 2018 it has built the company with its own capital and is selling innovative products in eight countries. By sourcing cannabis ingredients from its farm in Colombia, it offers German pharma-quality at affordable prices.”

“We are honored to be able to count on Howard’s advice and mentorship, including his views on the upcoming German adult-use regulations,” says FoliuMed founder Oliver Zugel. “His over 40 years of experience in business and politics and background as a successful entrepreneur make him a valued member of our Advisory Board.”

During his political career, Howard Glicken also has been National Vice Chairman of Finance of the Democratic Party, a member of the National Finance Board of Directors and a Managing Trustee of the Party. He also was State Finance Chair for Al Gore for President 1988, State Finance Chair for Senator Bob Kerrey for President in 1992, State Co-Finance Chair for President Clinton and a Trustee of the Vice President’s Residence Foundation.

Latest news

MGC Pharmaceuticals Releases Update On CimetrA Clinical Trial Progress In USA

MGC Pharmaceuticals Ltd (ASX, LSE: MXC, ‘MGC Pharma’ or ‘the Company’), a European based bio-pharma company specialising in the production and development...

European Cannabis Stocks Review: Akanda’s ‘Concerned Shareholders’ Oust All Directors Except CEO To Prevent ‘Potentially Irreparable Harm’ – More From Goodbody Health & Chill...

It has been another week of positive developments for the cannabis industry across Europe, with yet more markets making...

Analysis Shows UK Market Could Grow To Over £1bn By 2026 As London Prepares To Host Europe’s Leading Cannabis Conference

ANALYSIS shows UK market could grow to over £1bn by 2026 as London prepares to host Europe’s leading cannabis...

Medical Cannabis Could Be Available In Spain By The End Of The Year

SPAIN could now see the regulation and distribution of medical cannabis rolled out before the end of the year...

New UK Company Heralds Its ‘Unique’ Medical Cannabis Delivery Mechanism

CANNABIS extraction and formulations specialist 113 Botanicals is in the process of securing Good manufacturing Practice (GMP) compliance for...

German Cannabis Bill By Year End With Adult-Use Launch Likely In Early 2024

GERMANY’s draft cannabis law should be ready by the end of the year with the launch of its adult-use...

Must read

You might also likeRELATED
Recommended to you